Sign in to continue:

Thursday, March 5th, 2026

Third Coast Bancshares, Inc. (TCBX) 2025 Annual Report & 10-K Filing Highlights

Third Coast Bancshares, Inc. Files Annual Report (10-K) for Fiscal Year Ended December 31, 2025

Key Highlights from the 2025 Annual Report

  • Filing Details: Third Coast Bancshares, Inc. (NYSE: TCBX) has filed its annual report (Form 10-K) with the U.S. Securities and Exchange Commission for the fiscal year ended December 31, 2025.
  • Corporate Information: The company is headquartered at 20202 Highway 59 North, Suite 190, Humble, TX 77338. Main business phone: (281) 446-7000.
  • Stock Listing: Common Stock, par value \$1.00 per share, is listed on the New York Stock Exchange under the ticker symbol “TCBX”.
  • Regulatory Compliance: Third Coast Bancshares confirms it has filed all required reports under the Securities Exchange Act of 1934 for the preceding 12 months and has submitted all Interactive Data Files as required.

Investor-Sensitive and Potentially Price-Moving Information

  • Annual Report Status: The 10-K is an Annual Report and not a transition report. This confirms regular compliance and ongoing business operations.
  • Not a Well-Known Seasoned Issuer: The company explicitly indicates it is not a well-known seasoned issuer, which may impact perceptions of institutional investor interest and analyst coverage.
  • Exchange and Symbol Change: The report lists the New York Stock Exchange as its primary trading venue under the symbol TCBX, with a note that “NYSE Texas” is also referenced—investors should be alert to any changes or dual listings that could affect liquidity or trading patterns.
  • Regulatory Filing Status: TCBX confirms it is not a voluntary filer, and is not exempt from reporting obligations under Section 13 or 15(d) of the Securities Exchange Act. This ensures ongoing transparency for shareholders.
  • Filing Status: The company is not a large accelerated filer, which could affect index inclusion and investor awareness. It is also not an emerging growth company, indicating it has passed the early-stage company phase.

Other Notable Details for Shareholders

  • Securities Registered under Section 12(b):

    • Common Stock, \$1.00 par value is the only class registered for trading.
  • Securities Registered under Section 12(g):

    • No additional securities are registered under 12(g) – meaning no other classes of equity or debt are public.
  • Filing Compliance and Status:

    • TCBX has maintained compliance with all filing and submission requirements during the period, which is positive for governance and investor confidence.

Potential Price Sensitivity and Shareholder Considerations

  • The filing confirms no regulatory or compliance issues over the past year, which should reassure investors about the company’s operational and reporting rigor.
  • The reaffirmation of the NYSE listing and the absence of any new securities or classes may impact investor expectations for capital structure changes or future offerings.
  • Status as a non-accelerated filer and non-emerging growth company may impact analyst coverage and institutional investor interest, potentially influencing share liquidity and valuation.
  • Since the company is not a well-known seasoned issuer, it may have a lower profile among large asset managers and index funds, but remains in full compliance with all key reporting requirements.

Summary for Investors

The 2025 10-K filing by Third Coast Bancshares, Inc. presents no surprises or material non-public developments. The company is in full regulatory compliance, maintains a single class of common stock traded on the NYSE, and does not currently qualify as a large accelerated filer or a well-known seasoned issuer. While there are no new risk factors or disclosures that would be considered price-sensitive or likely to move the stock significantly, the report’s clean bill of health from a compliance and governance standpoint should be seen as reassuring for existing shareholders.

There are no significant new developments or events disclosed in this 10-K filing that would be considered highly price-sensitive at this time.

Disclaimer: This summary is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. Investors should consult the full SEC filings and their financial advisors before making any investment decisions.

View Third Coast Bancshares, Inc. Historical chart here



Apogee Therapeutics Reports 2025 Financial Results and Pipeline Progress for Zumilokibart in Atopic Dermatitis, Asthma, and Expansion Indications 12

Apogee Therapeutics Pipeline Progress & Full Year 2025 Financial Results Apogee Therapeutics Announces Significant Pipeline Progress and Robust Financial Position for 2025 Key Highlights for Investors Pipeline Advancements: APG777 (zumilokibart) continues to advance in...

Energy Vault Holdings, Inc. Files Form 8-K with NYSE Listing Details and Company Information

Energy Vault Holdings, Inc. – Key Developments in Recent 8-K Filing Energy Vault Holdings, Inc. Announces Entry into Material Agreements and Capped Call Transactions Key Points from the Form 8-K Filing Date of Report:...

VSee Health, Inc. Enters Managed Services and $2 Million Stock Purchase Agreements with GoMyRx – SEC 8-K Filing Details

VSEE Health, Inc. Files Form 8-K: Stock Purchase Agreement and Key Company Updates VSEE Health, Inc. (NASDAQ: VSEE), an emerging growth company, has filed a Form 8-K with the Securities and Exchange Commission (SEC),...

   Ad